CN Patent

CN109517022B — 五环三萜类化合物及其制备方法、药物组合物和用途

Assigned to Shanghai Institute of Materia Medica of CAS · Expires 2022-09-13 · 4y expired

What this patent protects

本发明公开了一种五环三萜类化合物及其制备方法、药物组合物和用途。五环三萜类化合物的结构如通式I所示。本发明的五环三萜类化合物，能有效拮抗FXR受体，与现有的一些天然来源的FXR拮抗剂相比，具有更丰富的天然来源和更简便的合成方法。

USPTO Abstract

本发明公开了一种五环三萜类化合物及其制备方法、药物组合物和用途。五环三萜类化合物的结构如通式I所示。本发明的五环三萜类化合物，能有效拮抗FXR受体，与现有的一些天然来源的FXR拮抗剂相比，具有更丰富的天然来源和更简便的合成方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN109517022B
Jurisdiction
CN
Classification
—
Expires
2022-09-13
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Institute of Materia Medica of CAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.